MYNX CONTROL Vascular Closure Device
MYNX CONTROL Vascular Closure Device
MYNX CONTROL Vascular Closure Device
The MYNX CONTROL Vascular Closure Device is part of Cordis’s market-leading MYNX closure platform — bringing dual-mode active sealing technology to femoral access site closure across 5Fr, 6Fr, and 7Fr arteriotomy sizes.
Mechanism of Action
The MYNX CONTROL’s defining innovation is its polyethylene glycol (PEG) sealant — a synthetic, biocompatible hydrogel that expands upon contact with blood at the arteriotomy, providing immediate external plug formation at the puncture site without any intravascular component.
The dual-mode active sealing mechanism allows the operator to select between direct gel advancement and a confirmatory re-seal mode, giving the interventionalist tactile and visual feedback of successful closure before withdrawing the device. The PEG sealant is designed to fully resorb within 30 days through hydrolytic degradation, leaving no permanent material at the arterial access site.
Product Gallery
Device Specs
| Field | Specification |
|---|---|
| Closure Mechanism | Fully extravascular PEG hydrogel plug; no intravascular component |
| Sealant Material | Polyethylene glycol (PEG) — synthetic biocompatible hydrogel |
| Active Sealing Modes | Dual-mode: direct gel advancement + confirmatory re-seal mode with tactile and visual feedback |
| Compatible Sheath Sizes | 5Fr, 6Fr, 7Fr |
| Resorption Timeline | Complete resorption within 30 days via hydrolytic degradation |
| Intravascular Component | None — fully extravascular deployment |